Veterinary Medicines

Orbeseal 2,6 g, intramammaarsuspensioon kinnislehmadele

Authorised
  • Bismuth subnitrate
Download as PDF

Product identification

Medicine name:
Orbeseal 2,6 g, intramammaarsuspensioon kinnislehmadele
Active substance:
  • Bismuth subnitrate
Target species:
  • Cattle (dairy cow at drying-off)
Route of administration:
  • Intramammary use

Product details

Active substance and strength:
  • Bismuth subnitrate
    2.60
    gram(s)
    /
    1.00
    Syringe
Pharmaceutical form:
  • Intramammary suspension
Withdrawal period by route of administration:
  • Intramammary use
    • Cattle (dairy cow at drying-off)
      • Meat and offal
        0
        day
      • Milk
        0
        hour
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QG52X
Legal status of supply:
  • Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Estonia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Zoetis Belgium
Marketing authorisation date:
Manufacturing sites for batch release:
  • Cross Vetpharm Group Limited
  • Haupt Pharma Latina S.r.l.
Responsible authority:
  • State Agency Of Medicines
Authorisation number:
  • 1156
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Estonian (PDF)
Published on: 4/04/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."